Hansoh Pharmaceutical Announces Interim Dividend for 2025

An announcement from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) is now available.

Hansoh Pharmaceutical Group Company Limited has announced an interim cash dividend of HKD 0.2316 per share for the six months ending June 30, 2025. This update includes changes to the timeline for lodging transfer documents for registration, the book close period, and the record date. The dividend will be paid on October 30, 2025, and reflects the company’s ongoing financial health and commitment to shareholder returns.

The most recent analyst rating on (HK:3692) stock is a Hold with a HK$37.00 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.

More about Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of innovative and high-quality pharmaceutical products. The company is known for its commitment to research and development, aiming to address unmet medical needs and improve patient outcomes.

Average Trading Volume: 12,714,650

Technical Sentiment Signal: Buy

Current Market Cap: HK$214.1B

Find detailed analytics on 3692 stock on TipRanks’ Stock Analysis page.